TrialCancer biology & medicine2024

Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.

Shuzhen Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.